Johnson & Johnson will stop selling talc-based baby powder globally in 2023, more than two years after it ended U.S. sales of a product that drew…

Johnson & Johnson and the three largest U.S. drug distributors have agreed to finalize a proposed $26 billion settlement resolving claims by stat…

EU regulators on Wednesday recommended Johnson & Johnson's shot for use as a booster dose. However, Sanofi and GlaxoSmithKline said they expe…

The U.S. Food and Drug Administration authorized booster doses of the COVID-19 vaccines from Moderna and Johnson & Johnson, and said Americans ca…

Outside advisers to the U.S. Food and Drug Administration voted unanimously to recommend regulators authorize a second shot of Johnson & Johnson&…

Johnson & Johnson plans to ask U.S. regulators to authorize a booster shot of its single-shot COVID-19 vaccine, according to a report by The New …

Johnson & Johnson may split into two companies to offload its Baby Powder liabilities and seek bankruptcy protection, which could result in lower…

Johnson & Johnson said that its COVID-19 vaccine is effective against the Delta variant of the novel coronavirus.

Experts are weighing the need for booster shots of the Pfizer/BioNTech, or Moderna mRNA-based vaccines for Americans who received Johnson & Johns…

South African President Cyril Ramaphosa said that Johnson & Johnson would send 2 million COVID-19 vaccine doses to the country by the end of the…

The EU's medical regulator has given a green light to the Johnson & Johnson COVID-19 vaccine despite a 'possible link' to rare blood …

The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous bl…

J&J will ship fewer COVID-19 shots around the U.S. until it receives FDA authorization for a vaccine plant in Baltimore, but remains on track to …

The U.S. has put Johnson & Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and stopped British drugmaker AstraZ…

The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in…

The European Union's drugs regulator approved Johnson & Johnson's single-dose COVID-19 vaccine, as the bloc seeks to speed up a stutterin…

Johnson & Johnson is facing supply issues that could mean it struggles to hit its target for delivering vaccines to the EU.

The new single-dose vaccine began shipping out Monday morning after the FDA issued emergency use authorization for the shot. It is the third COVID-19…

J&J says that the company expects to deliver 20 million doses of its coronavirus vaccine in the U.S. by the end of March.

South Africa will start vaccinating health workers with Johnson & Johnson's COVID-19 vaccine in an 'implementation study' to further …